Solara Active Pharma Sciences has informed that it attached press release issued by the Company titled: ‘USFDA concludes inspection at Solara’s Visakhapatnam (Vizag) facility with zero 483 inspectional observations.’
The above information is a part of company’s filings submitted to BSE.